{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T14:45:18Z","timestamp":1790347518393,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100009845","name":"Ovarian Cancer Research Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100009845","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","translationalres.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Research"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.trsl.2016.02.002","type":"journal-article","created":{"date-parts":[[2016,2,10]],"date-time":"2016-02-10T04:15:15Z","timestamp":1455077715000},"page":"83-95.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"C","title":["Annexin A2 and S100A10 are independent predictors of serous ovarian cancer outcome"],"prefix":"10.1016","volume":"171","author":[{"given":"Noor A.","family":"Lokman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen E.","family":"Pyragius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Ruszkiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin K.","family":"Oehler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmela","family":"Ricciardelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trsl.2016.02.002_bib1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3322\/caac.21254","article-title":"Cancer statistics, 2015","volume":"65","author":"Siegel","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.trsl.2016.02.002_bib2","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.2353\/ajpath.2010.100105","article-title":"Ovarian cancer development and metastasis","volume":"177","author":"Lengyel","year":"2010","journal-title":"Am J Pathol"},{"issue":"suppl 1","key":"10.1016\/j.trsl.2016.02.002_bib3","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1525-1438.2006.00503.x","article-title":"Molecular prognostic markers in ovarian cancer: toward patient-tailored therapy","volume":"16","author":"Crijns","year":"2006","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.trsl.2016.02.002_bib4","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s12307-011-0064-9","article-title":"The role of annexin A2 in tumorigenesis and cancer progression","volume":"4","author":"Lokman","year":"2011","journal-title":"Cancer Microenviron"},{"key":"10.1016\/j.trsl.2016.02.002_bib5","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.18632\/oncotarget.1122","article-title":"Annexin A2 is regulated by ovarian cancer-peritoneal cell interactions and promotes metastasis","volume":"4","author":"Lokman","year":"2013","journal-title":"Oncotarget"},{"key":"10.1016\/j.trsl.2016.02.002_bib6","first-page":"1","article-title":"Overexpression of ANXA2 predicts adverse outcomes of patients with malignant tumors: a systematic review and meta-analysis","volume":"32","author":"Liu","year":"2014","journal-title":"Med Oncol"},{"key":"10.1016\/j.trsl.2016.02.002_bib7","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1007\/s13277-013-0715-1","article-title":"Clinical significance of annexin II expression in human non-small cell lung cancer","volume":"34","author":"Jia","year":"2013","journal-title":"Tumor Biol"},{"key":"10.1016\/j.trsl.2016.02.002_bib8","doi-asserted-by":"crossref","first-page":"32512","DOI":"10.1074\/jbc.M112.351957","article-title":"Annexin A2 silencing induces G2 arrest of non-small cell lung cancer cells through p53-dependent and -independent mechanisms","volume":"287","author":"Wang","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.trsl.2016.02.002_bib9","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1007\/s12094-013-1028-y","article-title":"Prognostic significance of annexin II expression in non-small cell lung cancer","volume":"15","author":"Luo","year":"2013","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.trsl.2016.02.002_bib10","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/codi.12207","article-title":"Prognostic and diagnostic significance of annexin A2 in colorectal cancer","volume":"15","author":"Yang","year":"2013","journal-title":"Colorectal Dis"},{"key":"10.1016\/j.trsl.2016.02.002_bib11","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1002\/1097-0142(20010915)92:6<1419::AID-CNCR1465>3.0.CO;2-J","article-title":"Annexin II overexpression correlates with stromal tenascin-C overexpression","volume":"92","author":"Emoto","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.trsl.2016.02.002_bib12","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.ijpara.2010.05.002","article-title":"Up-regulation of annexin A2 in cholangiocarcinoma caused by Opisthorchis viverrini and its implication as a prognostic marker","volume":"40","author":"Yonglitthipagon","year":"2010","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.trsl.2016.02.002_bib13","first-page":"1339","article-title":"Annexin II overexpression is correlated with poor prognosis in human gastric carcinoma","volume":"21","author":"Emoto","year":"2001","journal-title":"Anticancer Res"},{"key":"10.1016\/j.trsl.2016.02.002_bib14","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/1477-7819-10-103","article-title":"Upregulated expression of annexin II is a prognostic marker for patients with gastric cancer","volume":"10","author":"Zhang","year":"2012","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.trsl.2016.02.002_bib15","doi-asserted-by":"crossref","first-page":"846","DOI":"10.3171\/2012.9.JNS112134","article-title":"Correlation of expression levels of ANXA2, PGAM1, and CALR with glioma grade and prognosis","volume":"118","author":"Gao","year":"2013","journal-title":"J Neurosurg"},{"key":"10.1016\/j.trsl.2016.02.002_bib16","doi-asserted-by":"crossref","first-page":"6259","DOI":"10.3390\/ijms14036259","article-title":"Annexin A2 heterotetramer: structure and function","volume":"14","author":"Bharadwaj","year":"2013","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.trsl.2016.02.002_bib17","doi-asserted-by":"crossref","first-page":"353687","DOI":"10.1155\/2012\/353687","article-title":"The biochemistry and regulation of S100A10: a multifunctional plasminogen receptor involved in oncogenesis","volume":"2012","author":"Madureira","year":"2012","journal-title":"J Biomed Biotechnol"},{"key":"10.1016\/j.trsl.2016.02.002_bib18","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S1357-2725(01)00046-2","article-title":"S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles","volume":"33","author":"Donato","year":"2001","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.trsl.2016.02.002_bib19","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0014-5793(01)02604-7","article-title":"Complex formation and submembranous localization of annexin 2 and S100A10 in live HepG2 cells","volume":"500","author":"Zobiack","year":"2001","journal-title":"FEBS Lett"},{"key":"10.1016\/j.trsl.2016.02.002_bib20","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.1007\/s13277-013-0962-1","article-title":"S100A10 as a novel biomarker in colorectal cancer","volume":"34","author":"Shang","year":"2013","journal-title":"Tumor Biol"},{"key":"10.1016\/j.trsl.2016.02.002_bib21","first-page":"2679","article-title":"S100A10 expression in thyroid neoplasms originating from the follicular epithelium: contribution to the aggressive characteristic of anaplastic carcinoma","volume":"27","author":"Ito","year":"2007","journal-title":"Anticancer Res"},{"key":"10.1016\/j.trsl.2016.02.002_bib22","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1349-7006.2006.00355.x","article-title":"Evaluation of S100A10, annexin II and B-FABP expression as markers for renal cell carcinoma","volume":"98","author":"Domoto","year":"2007","journal-title":"Cancer Sci"},{"key":"10.1016\/j.trsl.2016.02.002_bib23","first-page":"1","article-title":"Annexin A2 plays a critical role in epithelial ovarian cancer","author":"Deng","year":"2014","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.trsl.2016.02.002_bib24","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1158\/1078-0432.CCR-12-0056","article-title":"Multidrug resistance-linked gene signature predicts overall survival of patients with primary ovarian serous carcinoma","volume":"18","author":"Gillet","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.trsl.2016.02.002_bib25","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s10585-015-9718-1","article-title":"Transketolase is upregulated in metastatic peritoneal implants and promotes ovarian cancer cell proliferation","volume":"32","author":"Ricciardelli","year":"2015","journal-title":"Clin Exp Metastasis"},{"key":"10.1016\/j.trsl.2016.02.002_bib26","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1530\/ERC-11-0329","article-title":"Implementing an online tool for genome-wide validation of survival-associated biomarkers in ovarian-cancer using microarray data from 1287 patients","volume":"19","author":"Gyorffy","year":"2012","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.trsl.2016.02.002_bib27","doi-asserted-by":"crossref","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci Signal"},{"key":"10.1016\/j.trsl.2016.02.002_bib28","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov"},{"key":"10.1016\/j.trsl.2016.02.002_bib29","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nature10166","article-title":"Integrated genomic analyses of ovarian carcinoma","volume":"474","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.trsl.2016.02.002_bib30","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.jss.2012.05.065","article-title":"Akt\/mTOR signaling pathway is crucial for gemcitabine resistance induced by annexin II in pancreatic cancer cells","volume":"178","author":"Kagawa","year":"2012","journal-title":"J Surg Res"},{"key":"10.1016\/j.trsl.2016.02.002_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2014.08.015","article-title":"Annexin A2 in renal cell carcinoma: expression, function, and prognostic significance","volume":"33","author":"Yang","year":"2015","journal-title":"Urol Oncol"},{"key":"10.1016\/j.trsl.2016.02.002_bib32","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/sj.bjc.6605128","article-title":"Annexin II represents metastatic potential in clear-cell renal cell carcinoma","volume":"101","author":"Ohno","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1016\/j.trsl.2016.02.002_bib33","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1002\/ijc.29213","article-title":"Annexin-A2 as predictor biomarker of recurrent disease in endometrial cancer","volume":"136","author":"Alonso-Alconada","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.trsl.2016.02.002_bib34","doi-asserted-by":"crossref","first-page":"3984","DOI":"10.4161\/cc.8.23.10238","article-title":"The reverse Warburg effect: aerobic glycolysis in cancer associated fibroblasts and the tumor stroma","volume":"8","author":"Pavlides","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1016\/j.trsl.2016.02.002_bib35","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ygyno.2012.04.005","article-title":"Immunohistochemical expression of annexin A2 and S100A proteins in patients with bulky stage IB\u2013IIA cervical cancer treated with neoadjuvant chemotherapy","volume":"126","author":"Jin","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.trsl.2016.02.002_bib36","doi-asserted-by":"crossref","first-page":"4810","DOI":"10.1111\/j.1742-4658.2008.06620.x","article-title":"Matrilysin (matrix metalloprotease-7) cleaves membrane-bound annexin II and enhances binding of tissue-type plasminogen activator to cancer cell surfaces","volume":"275","author":"Tsunezumi","year":"2008","journal-title":"FEBS J"},{"key":"10.1016\/j.trsl.2016.02.002_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-4598-13-243","article-title":"Human epididymis protein 4 in association with annexin II promotes invasion and metastasis of ovarian cancer cells","volume":"13","author":"Zhuang","year":"2014","journal-title":"Mol Cancer"},{"key":"10.1016\/j.trsl.2016.02.002_bib38","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/sj.bjc.6604128","article-title":"Characterisation and protein expression profiling of annexins in colorectal cancer","volume":"98","author":"Duncan","year":"2008","journal-title":"Br J Cancer"},{"key":"10.1016\/j.trsl.2016.02.002_bib39","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.lungcan.2008.10.024","article-title":"Identification of metastasis associated proteins in human lung squamous carcinoma using two-dimensional difference gel electrophoresis and laser capture microdissection","volume":"65","author":"Yao","year":"2008","journal-title":"Lung Cancer"},{"key":"10.1016\/j.trsl.2016.02.002_bib40","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ygyno.2015.07.107","article-title":"Expression and clinical role of chemoresponse-associated genes in ovarian serous carcinoma","volume":"139","author":"Nymoen","year":"2015","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.trsl.2016.02.002_bib41","first-page":"853","article-title":"Proteomic-based analysis for identification of potential serum biomarkers in gallbladder cancer","volume":"26","author":"Tan","year":"2011","journal-title":"Oncol Rep"},{"key":"10.1016\/j.trsl.2016.02.002_bib42","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1016\/j.jprot.2012.02.012","article-title":"MALDI imaging mass spectrometry reveals COX7A2, TAGLN2 and S100-A10 as novel prognostic markers in Barrett's adenocarcinoma","volume":"75","author":"Elsner","year":"2012","journal-title":"J Proteomics"},{"key":"10.1016\/j.trsl.2016.02.002_bib43","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1002\/ijc.27747","article-title":"Gene-expression signature of tumor recurrence in patients with stage II and III colon cancer treated with 5\u2032fluoruracil-based adjuvant chemotherapy","volume":"132","author":"Gir\u00e1ldez","year":"2013","journal-title":"Int J Cancer"},{"key":"10.1016\/j.trsl.2016.02.002_bib44","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1093\/carcin\/bgs372","article-title":"Annexin A2 is a discriminative serological candidate in early hepatocellular carcinoma","volume":"34","author":"Sun","year":"2013","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.trsl.2016.02.002_bib45","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1002\/pmic.201300127","article-title":"Identification of annexin II as a novel secretory biomarker for breast cancer","volume":"13","author":"Jeon","year":"2013","journal-title":"Proteomics"},{"key":"10.1016\/j.trsl.2016.02.002_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jnci\/dju249","article-title":"Prognostic and therapeutic relevance of molecular subtypes in high-grade serous ovarian cancer","volume":"106","author":"Konecny","year":"2014","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.trsl.2016.02.002_bib47","doi-asserted-by":"crossref","first-page":"5198","DOI":"10.1158\/1078-0432.CCR-08-0196","article-title":"Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome","volume":"14","author":"Tothill","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.trsl.2016.02.002_bib48","first-page":"517","article-title":"Prognostically relevant gene signatures of high-grade serous ovarian carcinoma","volume":"123","author":"Verhaak","year":"2013","journal-title":"J Clin Invest"}],"container-title":["Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524416000566?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524416000566?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,15]],"date-time":"2018-09-15T15:20:05Z","timestamp":1537024805000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1931524416000566"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":48,"alternative-id":["S1931524416000566"],"URL":"https:\/\/doi.org\/10.1016\/j.trsl.2016.02.002","relation":{},"ISSN":["1931-5244"],"issn-type":[{"value":"1931-5244","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Annexin A2 and S100A10 are independent predictors of serous ovarian cancer outcome","name":"articletitle","label":"Article Title"},{"value":"Translational Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trsl.2016.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}